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Abstract
Purpose Substantial differences between sexes exist with respect to cardiovascular diseases, including congenital heart 
disease. Nevertheless, clinical decisions in the long-term follow-up of patients with repaired tetralogy of Fallot (rTOF) are 
currently based on unisex thresholds for cardiac magnetic resonance (CMR) measurements. This study aimed to assess 
whether sex differences exist in cardiac adaptation to hemodynamic loading conditions in patients with rTOF. Methods 
and Results This cross-sectional, two-center, combined pediatric and adult cohort included 320 rTOF patients (163 males, 
51%) who underwent routine CMR. Despite similar age (median and interquartile range [m + IQR] 23.4 [15.2–34.4] years), 
surgical history, and hemodynamic loading, males with rTOF demonstrated higher biventricular CMR-derived volumes 
and masses, indexed for body surface area, compared to females (e.g. m + IQR right ventricular (RV) end-diastolic volume: 
males 123 [100–151] mL/m2, females 114 [94–131] mL/m2, P = 0.007). Sex-specific Z-scores of biventricular volumes and 
masses were similar for males and females. RV volumes and masses correlated with hemodynamic loading, but these rela-
tions did not differ between sexes. Biventricular ejection fraction (EF) appeared to be lower in male patients, compared to 
female patients (e.g. m + IQR RVEF: males 48 [43–54]%, females 52 [46–57]%, P < 0.001). Conclusion Indexed ventricular 
volumes and masses are higher in males with rTOF, compared to females, similar to the healthy population. RV hypertrophy 
and dilatation correlated to loading conditions similarly for both sexes. However, under comparable loading conditions, males 
demonstrated more severe functional impairment. These results indicate that sex-differences should no longer be ignored in 
treatment strategies, including timing of pulmonary valve replacement.
Keywords Tetralogy of Fallot · Cardiac magnetic resonance · Sex · Sex differences · Pulmonary valve replacement
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Introduction
Tetralogy of Fallot (TOF) is one of the most prevalent 
congenital heart diseases, with excellent and mostly symp-
tom-free survival into adulthood after surgical repair in 
the current era [1, 2]. However, patients remain at risk of 
progressive right ventricular (RV) dilatation and deteriora-
tion of cardiac function on the longer term [2, 3]. Timing 
of major clinical decisions, for example pulmonary valve 
replacement (PVR), is therefore key [4]. Cardiac magnetic 
resonance (CMR) derived measures of ventricular morphol-
ogy and function form the cornerstone of decision making 
in the long-term follow-up of patients with repaired TOF 
(rTOF).
Currently, timing of PVR, for instance, is heavily based 
on CMR-derived RV volume thresholds, without distinc-
tion between sexes [5, 6]. However, it has been increasingly 
recognized in recent years that substantial differences exist 
between healthy men and women with respect to cardiac 
volumes and masses. In the healthy population, even after 
indexing for body surface area (BSA), males appear to 
have approximately 10% higher indexed volumes of both 
ventricles, and approximately 20% higher indexed mass of 
both ventricles, compared to women [7–9]. Ejection frac-
tion (EF) did not differ between healthy men and women in 
these reports. Also in patients with congenital heart disease 
(CHD), relevant sex differences are increasingly recognized 
[10]. For example, females are more frequently symptomatic 
[11] and are more prone to develop pulmonary hypertension 
[12, 13], whereas the occurrence of arrhythmia and mortal-
ity is higher in males [14–16]. Further, similar to the healthy 
population, male rTOF patients appear to have higher biven-
tricular volumes and mass (indexed for BSA) compared to 
female patients, despite equal hemodynamic burden and 
surgical history [17, 18].
The observation that biventricular volumes and mass 
differ substantially, both in the healthy population and the 
rTOF population, even when indexed for BSA, suggests that 
indication thresholds for interventions should be sex-specific 
[19]. However, the course of cardiac dimensions per sex in 
the rTOF population beyond the age of 20 years, relatively 
to healthy subjects, has not been described to date. Further-
more, it is unknown whether biventricular adaptation to 
abnormal loading conditions in rTOF might be different for 
male and female patients. The aim of the present study was 
to assess whether sex differences exist in cardiac adaptation 
to loading conditions in a combined American and Dutch, 




Patients with rTOF, who underwent CMR imaging between 
January 2007 and May 2016 in Stanford University Medical 
Center (SUMC) or University Medical Center Groningen 
(UMCG) were retrospectively included, as reported previ-
ously [16]. Pulmonary atresia and absent pulmonary valve 
were excluded. Only patients between 8 and 60 years of age 
were included to adhere to the lowest age for which normal 
values are available [7], and since above 60 years of age, 
patient numbers were insufficient to make adequate com-
parisons. The need for individual informed consent for this 
study was waived by institutional Medical Ethical Review 
Boards of participating sites. This study has been performed 
in accordance with the ethical standards laid down in the 
1964 Declaration of Helsinki and its later amendments.
Patient characteristics, echo‑ 
and electrocardiography
Patient characteristics (i.e. age, sex, length, height) and 
medical history (i.e. occurrence of palliative shunt, date and 
type of TOF repair, any re-intervention) were extracted from 
records. The echocardiographic study and electrocardiogram 
closest to CMR, only if performed within 3 months from 
CMR and without relevant interventions in the time between 
echocardiography and CMR, were identified. Pulmonary 
valve (PV) peak gradient was extracted from echocardio-
graphic report. The electrocardiogram was used to measure 
QRS duration.
CMR analysis
CMR images were analyzed by three observers (T.M.G., 
N.E.G.B., or Q.A.J.H.) using QMass 7.6 (Medis, Leiden, 
The Netherlands) to measure biventricular volumes and 
mass. Good intra- and inter-observer variability analyses of 
these three observers have been reported previously [16]. 
Short-axis epi- and endocardial borders of both ventricles 
were traced manually in end-systole and end-diastole, in 
accordance with guidelines of the Society of Cardiovascular 
Magnetic Resonance. RV outflow tract was included in RV 
volume until the PV. Trabecular mass and papillary mus-
cle mass were included into ventricular mass using MassK 
mode (semi-automatic threshold-based segmentation) [20]. 
Pulmonary flow (phase-contrast) was measured using QFlow 
5.6 (Medis, Leiden, The Netherlands), after which pulmo-
nary regurgitant fraction (PRF) was calculated. Post-pro-
cessing background offset correction was performed, based 
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on previous experience [21]. Volumes and masses were 
indexed for BSA using Haycock’s formula.
Healthy reference cohorts
As reference cohort of healthy subjects from 8 to 20 years 
of age, a cohort of 49 girls and 49 boys, previously reported, 
was used [7]. In this report, subjects were grouped into 8–16, 
and 16–20 years of age. As reference cohort of healthy sub-
jects beyond 20 years of age, a previously reported cohort 
of 60 men and 60 women was used, of which RV and LV 
data are published separately [8, 9]. In these studies, sub-
jects were grouped into 10-year age groups. Patients in 
the present study cohort were grouped accordingly. These 
healthy reference cohorts were chosen since, in accordance 
with our method of CMR analysis, threshold-based analyses 
were used to exclude papillary muscles and trabecular struc-
tures from ventricular volumes, and to include in ventricular 
masses. Z-scores were calculated for every patient, using 
sex-specific and age-group specific normal values from the 
reference cohorts.
Statistics
Data were presented as numbers and percentages or 
median and interquartile range (IQR). Continuous vari-
ables were compared between sexes using Mann–Whitney 
U test, categorical variables were using Chi-squared test. 
One-sample Wilcoxon signed rank test was performed to 
assess whether Z-scores were significantly different from 
zero. To assess whether PVR might have biased results, 
subgroup analyses of patients with PVR, and patients with-
out PVR, were performed. Linear regression of CMR vari-
ables with echo PV peak gradient, PRF and age was per-
formed. For linear regression, CMR variables and Z-scores 
of CMR variables that were not normally distributed were 
transformed until normal distribution was reached (defined 
as visually normal distribution on histogram and Q-Q plot, 
and a Kolmogorov–Smirnov P-value > 0.05). To assess 
whether associations with PV peak gradient are different 
between sexes, linear regression of CMR variables was 
performed with PV peak gradient, sex, and an interaction 
term of PV peak gradient multiplied by sex. When the P 
value of the interaction term was < 0.05, we rejected the 
null hypothesis that sexes have similar associations with 
PV peak gradient. Similar procedures were used to assess 
Table 1  Study population 
characteristics
BMI body mass index, BSA body surface area, TAP trans-annular patch, PVR pulmonary valve replace-
ment, CMR cardiac magnetic resonance, PC phase-contrast, PRF pulmonary regurgitant fraction, PV pul-
monary valve. P values below 0.05 are displayed in bold.
Male (n = 163) Female (n = 157) P value
Patient characteristics
Age (years) 23.0 [15.7–33.5] 23.9 [10.1–52.8] 0.965
BMI (kg/m2) 23.8 [20.0–26.0] 22.2 [19.7–25.6] 0.084
BSA  (m2) 1.9 [1.6–2.1] 1.6 [1.4–1.8]  < 0.001
History
Age at repair (years) 1.3 [0.0–13.0] 1.4 [0.0–11.0] 0.877
Shunt palliation 32 (19.6%) 36 (22.9%) 0.471
Correction type 0.955
- No TAP 25 (15.3%) 25 (15.9%)
- TAP 86 (52.8%) 88 (56.1%)
- Conduit 5 (3.1%) 6 (3.8%)
- Unknown 47 (28.8%) 38 (24.2%)
PVR prior to CMR 32 (19.6%) 26 (16.6%) 0.476
Redo-PVR prior to CMR 3 (1.8%) 2 (1.3%) 0.683
Age at first PVR (years) 24.7 [16.5–37.6] 23.7 [14.6–36.6] 0.832
Electrocardiography (n = 275)
QRS duration (ms) 148.5 [124.0–164.5] 138.0 [116.0–152.0] 0.003
Cardiac magnetic resonance PC-flow
PRF (%) 30.0 [16.0–42.0] 28.8 [17.0–38.8] 0.509
Cardiac index (L/min/m2) 3.0 [2.5–3.6] 3.1 [2.6–3.7] 0.382
Echocardiography (n = 241)
PV peak gradient (mmHg) 20.2 [12.4–33.3] 19.0 [13.1–29.6] 0.830
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differences in associations with PRF, age, and age at repair 
between sexes. To allow clinical interpretation of the data, 
B-coefficients of the untransformed CMR data were dis-
played. Statistical significance was considered achieved 
at a P value < 0.05.
Results
Study population
A total of 320 patients, consisting of 163 (51%) male 
patients and 157 (49%) female patients, were included. Of 
these, 112 patients (35%) were under the age of 18 years. 
Study population characteristics are displayed in Table 1. 
Age at CMR, age at TOF-repair, surgical history, body mass 
index (BMI), PRF, PV peak gradient and cardiac index were 
similar between males and females. Older patients received 
their surgical repair at an older age compared to younger 
patients, reflecting the evolving surgical practice and tim-
ing over time, but no sex bias was observed in the timing of 
surgery (Supplemental Fig. 1). PRF ranged from 0 to 80%, 
and PV peak gradient ranged from 0 to 85 mmHg. QRS 
duration and BSA were significantly higher in male patients.
CMR variables compared to normal
Table 2 displays CMR variables, either indexed for BSA, or 
expressed as Z-score relative to healthy subjects. Regarding 
the RV, both male and female patients with rTOF demon-
strate substantially higher indexed RV end-diastolic volume 
(RVEDVi), higher indexed RV mass (RVMi), and lower 
RV ejection fraction (RVEF), compared to healthy sub-
jects. Regarding the LV, both male and female patients with 
rTOF demonstrate decreased LV ejection fraction (LVEF), 
and a mildly decreased indexed LV end-diastolic volume 
(LVEDVi) and indexed LV mass (LVMi), compared to 
healthy subjects.
Sex differences in CMR variables
Indexed CMR variables all differed significantly between 
sexes (Table 2). Roughly, males appeared to have 10% higher 
indexed ventricular volumes, 20% higher indexed ventricu-
lar masses and lower EF of both ventricles. However, when 
normalized for sex and age (Z-score), only RVEF and LVEF 
were lower in males compared to females. To be able to 
compare with previous studies, subgroup analysis of patients 
within the age range of 8 to 20 years was performed [7, 17]. 
To assess whether sex differences are similarly present in 
young children, subgroup analysis of patients within the age 
range of 8 to 12 years was performed. Furthermore, to assess 
whether PVR might have influenced the described results, 
subgroup analyses of patients with and without PVR were 
performed. All these subgroup analyses demonstrate results 
that are similar to the complete study cohort (Supplemental 
Table 1).
Association with RV pressure load, RV volume load, 
age and age at repair
Associations with PV peak gradient, PRF, age, and age of 
repair are displayed in Table 3. All RV, but no LV vari-
ables correlated with RV pressure load, represented by PV 
peak gradient: RVEF and RVMi were higher at higher RV 
pressure load, whereas RV volumes were lower at higher 
RV pressure load. These associations did not differ signifi-
cantly between sexes. Furthermore, LV variables correlated 
Table 2  CMR variables by sex
CMR cardiac magnetic resonance, LVEF LV ejection fraction, LVEDVi LV indexed end-diastolic volume, LVESVi LV indexed end-systolic vol-
ume, LVMi LV indexed mass, RVEF RV ejection fraction, RVEDVi RV indexed end-diastolic volume, RVESVi RV indexed end-systolic volume, 
RVMi RV indexed mass
The displayed P-values are from male–female comparisons. The medians of all Z-scores are significantly different from zero (P < 0.001, not dis-
played). P values below 0.05 are displayed in bold.
Indexed CMR variables P value Z-scores of CMR variables P value
Male Female Male Female
LVEF (%) 57.7 [52.0–62.6] 60.0 [54.9–65.0] 0.013 − 1.60 [− 2.80 to − 0.43] − 0.87 [− 2.05 to 0.00] 0.003
LVEDVi (mL/m2) 80.6 [67.3–92.6] 73.1 [63.3–85.6] 0.002 − 0.44 [− 1.82 to 0.78] − 0.68 [− 1.71 to 0.54] 0.726
LVESVi (mL/m2) 34.5 [25.2–42.2] 28.6 [24.2–35.6] 0.001 0.67 [− 0.65 to 2.13] 0.15 [− 0.68 to 1.54] 0.219
LVMi (g/m2) 57.5 [49.9–68.8] 47.3 [41.6–55.1] < 0.001 − 0.84 [− 2.20 to 0.20] − 1.12 [− 2.08 to to − 0.16] 0.462
RVEF (%) 47.7 [42.8–54.1] 52.3 [46.4–57.3] < 0.001 − 2.65 [− 3.52 to − 1.46] − 2.10 [− 3.00 to − 0.97] 0.001
RVEDVi (mL/m2) 122.5 [99.5–151.4] 114.4 [94–131.1] 0.007 3.00 [1.10 to 5.58] 3.72 [1.36 to 5.49] 0.339
RVESVi (mL/m2) 64.4 [48.1–79.7] 52.5 [41.4–66.8] < 0.001 4.57 [2.31 to 6.74] 3.84 [2.30 to 6.35] 0.210
RVMi (g/m2) 44.4 [36.1–52.1] 34.3 [29.7–41.2] < 0.001 2.27 [1.38 to 3.33] 2.10 [0.42 to 3.61] 0.340
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with RV volume load, represented by PRF: LVEF and LVMi 
were lower at greater RV volume load, while RV volumes 
and RVMi were higher at greater RV volume load. Both RV 
and LV mass were higher at higher age, whereas RVEF was 
lower at higher age. Neither of these associations differed 
significantly between sexes. None of the CMR variables cor-
related with age at repair. Linear regression analyses were 
additionally performed with Z-score values, with similar 
results, as displayed in Supplemental Table 2. The only rel-
evant difference was that LVEF Z-score, but not LVEF, was 
lower at higher age (B-coefficient − 0.032, P value < 0.001, 
 R2 0.045), indicating that older patients with repaired TOF 
demonstrate more impairment of biventricular systolic func-
tion compared to younger patients. No associations between 
CMR variables and age at TOF correction were demon-
strated (not displayed). A graphical depiction of indexed 
CMR variables in different age groups, superimposed on 
normal values, is provided in Fig. 1 and Supplemental Fig. 2. 
Median Z-scores of different age groups are displayed in 
Supplemental Fig. 3.
Discussion
The present study in a comprehensive cohort of patients with 
rTOF, ranging from 8 to 60 years of age, identified substan-
tial differences in indexed CMR-derived measures of cardiac 
size and function between males and females. Whilst clinical 
characteristics, such as age, surgical history, and loading 
conditions of the RV did not differ between sexes, males 
appeared to have longer QRS duration and about 10% higher 
left and right ventricular volumes and 20% higher right and 
left ventricular masses, even after indexing for BSA, when 
compared to females. These differences are similar to dif-
ferences in the healthy population, where males also have 
larger and heavier hearts [7–9]. After normalizing for sex, 
by creating sex-specific Z-scores according to healthy refer-
ence values, no differences in volumes and masses between 
males and females with rTOF remained. This indicates that 
male and female patients with rTOF demonstrate a similar 
deviation from healthy subjects, and thus demonstrate simi-
lar cardiac remodeling in response to comparable loading 
conditions.
Surgical history and hemodynamic burden were com-
pared between sexes to assess whether they might have 
biased results. At first, hemodynamic burden at the time 
of CMR was demonstrated to be equal between sexes. Fur-
thermore, no differences in timing of repair surgery, type of 
repair surgery and frequency of the need for shunt palliation 
were observed between sexes (Table 1 and Supplemental 
Fig. 1). This demonstrates that there is no indication that 
disease severity or treatment strategies differed between 
sexes. Also after initial surgical repair, no difference in the 
timing or frequency of PVR were observed as the percent-
age of patients with PVR and the age at first PVR was simi-
lar between men and women. Finally, the observed ratio 
male:female did not differ between both the subgroup of 
Table 3  Linear regression with PV peak gradient, PRF, age and age 
at repair
PV pulmonary valve, PRF pulmonary regurgitant fraction, LVEF LV 
ejection fraction, LVEDVi LV indexed end-diastolic volume, LVESVi 
LV indexed end-systolic volume, LVMi LV indexed mass, RVEF RV 
ejection fraction, RVEDVi RV indexed end-diastolic volume, RVESVi 
RV indexed end-systolic volume, RVMi RV indexed mass. P values 
below 0.05 are displayed in bold.
B-coefficient P value R2 Interaction 
with sex (P 
value)
PV peak gradient
 LVEF (%) 0.052 0.169 0.008 0.592
 LVEDVi (mL/m2) − 0.049 0.496 0.002 0.943
 LVESVi (mL/m2) − 0.081 0.148 0.009 0.890
 LVMi (g/m2) 0.054 0.421 0.003 0.772
 RVEF (%) 0.070 0.026 0.021 0.971
 RVEDVi (mL/m2) − 0.365 0.019 0.023 0.820
 RVESVi (mL/m2) − 0.262 0.003 0.036 0.859
 RVMi (g/m2) 0.089 0.028 0.020 0.722
PRF
 LVEF (%) − 0.072 0.021 0.017 0.290
 LVEDVi (mL/m2) − 0.093 0.115 0.008 0.728
 LVESVi (mL/m2) 0.009 0.938 < 0.001 0.620
 LVMi (g/m2) − 0.160 0.005 0.026 0.896
 RVEF (%) − 0.004 0.882 < 0.001 0.842
 RVEDVi (mL/m2) 1.219 < 0.001 0.344 0.505
 RVESVi (mL/m2) 0.636 < 0.001 0.225 0.488
 RVMi (g/m2) 0.204 < 0.001 0.095 0.685
Age
 LVEF (%) − 0.046 0.300 0.003 0.517
 LVEDVi (mL/m2) − 0.025 0.747 < 0.001 0.197
 LVESVi (mL/m2) 0.022 0.735 0.000 0.277
 LVMi (g/m2) 0.279 < 0.001 0.058 0.224
 RVEF (%) − 0.080 0.016 0.018 0.794
 RVEDVi (mL/m2) − 0.043 0.442 0.002 0.442
 RVESVi (mL/m2) 0.079 0.752 < 0.001 0.566
 RVMi (g/m2) 0.151 0.001 0.033 0.742
Age at repair
 LVEF (%) − 0.135 0.170 0.006 0.162
 LVEDVi (mL/m2) − 0.383 0.052 0.013 0.763
 LVESVi (mL/m2) − 0.062 0.656 0.001 0.405
 LVMi (g/m2) − 0.136 0.052 0.013 0.062
 RVEF (%) − 0.126 0.140 0.007 0.535
 RVEDVi (mL/m2) − 0.363 0.148 0.007 0.437
 RVESVi (mL/m2) − 0.009 0.614 0.001 0.413
 RVMi (g/m2) 0.182 0.135 0.008 0.211
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patients without PVR (131 males, 131 females), and the sub-
group of patients who received PVR (32 males, 26 females, 
Supplemental Table 1). Together, these findings suggest that 
history and disease severity did not form a confounding fac-
tor in this study.
The degree of RV dilatation (RVEDVi) and RV hyper-
trophy (RVMi) correlated with volume- and pressure load 
respectively. RV volumes were smaller at higher RV pressure 
load, and larger with increasing RV volume load, indica-
tive of concentric and eccentric remodeling, respectively. 
RV mass was higher with both increasing RV pressure and 
volume load. The association of increasing pressure load 
with hypertrophy, decreasing RV volumes and increasing 
RVEF probably reflects compensated concentric hyper-
trophic remodeling in the minority of patients with signifi-
cantly increased PV gradient. Interestingly, LVEF and LV 
mass were lower with increasing RV volume load. However, 
none of these associations between cardiac measures and 
ventricular loading conditions or age differed significantly 
between sexes. These findings suggest that male and female 
rTOF patients respond similarly to abnormal loading condi-
tions of the RV and increasing age with respect to ventricular 
volumes and mass.
With respect to ventricular function, both RVEF and 
LVEF were decreased in patients with rTOF, compared to 
healthy reference values. This observation is in line with 
previous reports [3, 17]. After normalizing for sex-spe-
cific healthy reference values (by means of Z-scores), this 
decrease in biventricular EF was larger in males compared 
to females with rTOF. This is in contrast to the healthy 
population, where LVEF and RVEF do not differ between 
men and women [7–9]. Since biventricular EF is already 
lower in the subgroup of rTOF patients within 8–12 years 
of age, it seems unlikely that comorbidities, such as athero-
sclerotic disease, can be held accountable for the lower EF 
in male patients. The unfavorable functional adaptation of 
male patients in comparison to females could have conse-
quences for outcome. For example, our group and others 
have demonstrated previously that male sex is a risk fac-
tors for arrhythmia in rTOF [12, 14–16]. While remaining 
speculative, this could indicate that the unfavorable func-
tional adaptation in males contributes to an increased risk 
of arrhythmia. Taken together, functional adaptation of the 
RV is impaired in male rTOF patients, when compared with 
female patients with similar age, surgical history, RV load-
ing conditions and similar degrees of RV dilatation and RV 
hypertrophy.
Fig. 1  Sex-specific CMR variables in various age groups of patients 
with rTOF. Median and interquartile range of rTOF patients in blue 
(males) or red (females), superimposed on 95% confidence interval 
(1.96 SD) of healthy children and adolescents (8–20  years) [7] and 
adults (20–60  years) [8, 9] per age group. RVEF RV ejection frac-
tion, LVEF LV ejection fraction, RVEDVi RV indexed end-diastolic 
volume, RVESVi RV indexed end-systolic volume, RVMi RV indexed 
mass
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These findings seem to be in striking contrast with those 
of Sarikouch et al. who also found lower RVEF in males 
with rTOF compared to females, but after normalization 
for sex, reported a lower Z-score of RVEF in females 
compared to males [22]. This is remarkable and difficult 
to understand, since the cohort of this study, and that of 
Sarikouch et al. show very similar mean RVEF values, 
and use the same healthy reference cohort for Z-score cal-
culation. Review of these published reports shows that in 
the healthy reference cohorts, there were no significant 
differences in RVEF between sexes, whereas in the rTOF 
population of the Sarikouch-cohort, RVEF was signifi-
cantly lower in male patients compared to female patients 
(48.9% ± 6.7 in men, 53.4% ± 5.8 in women, P < 0.001). 
Then, it is hard to explain that the RVEF Z-score in men 
suddenly is higher than that in women. Thus, the lower 
RVEF Z-scores in men, described in the present study, are 
more plausible to adequately depict a more pronounced 
decrease of RVEF in male patients compared to female 
patients under similar conditions.
Sex hormones may play a role in these observed dif-
ferences in biventricular systolic function between men 
and women with rTOF. In cardiovascular disease-free 
subjects, a large study has demonstrated that higher lev-
els of estradiol were associated with higher RVEF [23, 
24]. Furthermore, animal studies suggest that estrogen 
can preserve both RV and LV contractility [25–27]. This 
protective characteristic of female sex hormones might 
also be observed in pulmonary arterial hypertension, 
where female patients demonstrate improvement of RVEF 
after treatment, whereas males demonstrate deterioration, 
despite comparable baseline disease severity [28]. How-
ever, the observed differences between males and females 
were already present in patients younger than 12 years of 
age. Most patients in this age group are pre-pubertal, and 
although some patients may have reached puberty prior 
to the age of 12, the amount of time exposed to post-
pubertal levels of sex hormones is little. This suggests 
that, besides possible hormonal factors, other mechanisms 
additionally play a role in the differences between male 
and female patients. Taken together, evidence is increas-
ing that female sex, or female sex hormones, beneficially 
influences cardiac function.
The commonly used absolute unisex criteria for RV 
volume as indication for PVR may erroneously cause 
female patients to reach operation indications later, at a 
more advanced stage of dilatation, compared to males. 
Furthermore, male patients with rTOF and dilated RV 
might need PVR earlier than female patients with simi-
lar dilatation, due to the occurrence of more or earlier 
deterioration of RV function. With this in mind, one 
could expect that men would receive PVR at a younger 
age, and more often, compared to female patients. In the 
current study, however, men and women demonstrated 
similar rates of PVR, and men were not younger at the 
time of first PVR. Speculatively, this might be due to 
women reaching other indications for PVR earlier than 
men. For example, female patients with CHD have lower 
exercise capacity, and are more frequently symptomatic, 
compared to male patients [11, 22]. This apparent dis-
crepancy between this unfavorable clinical state in women 
with rTOF, whereas they have less impaired ventricular 
function, compared to men, requires further study. Also, 
it remains unknown if referral bias, or other sex biases in 
the physician’s approach towards patients, plays any role 
in this matter.
Moreover, one might expect that, if women reach oper-
ation thresholds at a relatively more advanced stage of RV 
dilatation compared to men, outcome after PVR would 
be less favorable in women. However, studies addressing 
outcomes after PVR are flawed by sex differences, since 
these studies use unisex CMR-derived criteria to assess 
RV normalization [29, 30]. Using such unisex criteria will 
result in women reaching the RV normalization definition 
earlier and thus presumably more frequent. Therefore, the 
previously reported finding that female sex is a favorable 
predictor for RV normalization after PVR in rTOF should 
be interpreted with suspicion [29].
The results of the current study have relevant conse-
quences for clinical practice. The observed sex differ-
ences in the rTOF population are currently not taken 
into account in guidelines addressing the cutoff points 
for interventions, such as PVR, in patients with rTOF 
and residual lesions [5, 6]. The current findings implicate 
that diagnostic and treatment recommendations should 
be sex-specific, and both confirm and underscore previ-
ous suggestions in this direction [17–19, 31]. The present 
study demonstrates that, as long as RV dimensions and 
function are recommended and widely used as indication 
for PVR, sex-differences should no longer be ignored in 
treatment strategies. Future studies are needed to evalu-
ate whether sex-specific treatment strategies can improve 
clinical outcomes.
Limitations
This is a retrospective study, including patients over a 
10-year period. A limitation of any cross-sectional study, 
relating measures of disease severity to age in the rTOF 
population, is that older patients have had their surgical 
repair and neonatal treatment in a different era and at differ-
ent pre-repair conditions. These factors may confound the 
observed sex-related differences and could raise the ques-
tion whether the observed differences in EF were caused 
by pre-repair differences or differential functional adapta-
tion to abnormal loading. However, we found no differences 
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between sexes with regards to patient characteristics, surgi-
cal history, age at repair and age at first PVR. Furthermore, 
only patients who underwent a CMR were included, which 
may have introduced a selection bias. However, as current 
guidelines prescribe CMR imaging as the modality of choice 
for assessment of RV volume and function, CMR imaging 
is performed routinely, limiting such biases [5]. Unfortu-
nately, we did not have ethnicity nor history of pregnancy 
available. However, the present study describes lower RV 
volumes in female patients, compared to male patients, 
whereas pregnancy is known to increase RV volumes [32]. 
Therefore, it seems unlikely that the described differences 
between sexes result from pregnancy. However, the apparent 
increase in RVEDVi in females between the ages of 20 and 
40 years may have been driven by an effect of pregnancy. 
This hypothesis can unfortunately not confirmed in the pre-
sent study. Differences in all CMR variables are nevertheless 
present in all age groups, including the subgroup analysis of 
patients between 8 and 12 years of age. Also, despite that the 
current study included a relatively large and intercontinental 
cohort, numbers per sex in each age group are modest, limit-
ing statistical power. At last, comparability with studies that 
calculate standard deviation scores, instead of Z-scores as 
calculated in the present study, may be limited due to differ-
ent statistical approaches. However, it is unlikely that either 
method would cause systematic error, and therefore, it seems 
unlikely that this methodological discrepancy significantly 
influenced results.
Conclusion
As in the normal population, ventricular volumes and masses 
in patients with rTOF, indexed for BSA, are substantially 
higher in males, compared to females, suggesting the same 
pattern of morphological adaptation to abnormal loading. 
However, under comparable loading conditions, biventricu-
lar systolic function was lower in male patients, compared to 
female patients. These results suggest that research and treat-
ment recommendations need more focus on sex differences, 
including the use of sex-specific thresholds or Z-scores for 
timing of pulmonary valve replacement.
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